Jaguar Health (JAGX) Interest Expenses (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Interest Expenses of $1.7 million for Q1 2026, up 215.72% year-over-year from $547000.0 in Q1 2025, and up 412.46% quarter-over-quarter from $337000.0 in Q4 2025.
Jaguar Health (JAGX) Interest Expenses (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Interest Expenses for 13 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 215.72% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 215.72% YoY), while the FY2025 annual figure was $1.8 million, down 98.05% from the prior year.
- Interest Expenses advanced to $1.7 million in Q1 2026 per JAGX's latest filing, from $337000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $5.6 million in Q1 2024 and bottomed at -$1.4 million in Q4 2022.
- Historically, Interest Expenses has averaged $1.9 million across 5 years, with a median of $1.8 million in 2024.
- Annual changes were most pronounced in 2025 — Interest Expenses tumbled 90.15% — and 2026, when it soared 215.72%.
- Jaguar Health's Interest Expenses stood at -$1.4 million in 2022, then jumped by 110.07% to $141000.0 in 2023, then fell by 21.99% to $110000.0 in 2024, then soared by 206.36% to $337000.0 in 2025, then soared by 412.46% to $1.7 million in 2026.
- Business Quant data shows JAGX's Interest Expenses at $1.7 million in Q1 2026, $337000.0 in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 699,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.73 Mn |
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 337,000.00 |
| Dec 31, 2025 | 337,000.00 |
| Sep 30, 2025 | 1.82 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Jun 30, 2025 | 2.08 Mn |
| Mar 31, 2025 | 547,000.00 |
| Mar 31, 2025 | 547,000.00 |
| Dec 31, 2024 | 110,000.00 |
| Dec 31, 2024 | 110,000.00 |
| Sep 30, 2024 | 1.80 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 1.85 Mn |
| Mar 31, 2024 | 5.56 Mn |
| Mar 31, 2024 | 5.56 Mn |
| Dec 31, 2023 | 141,000.00 |
| Dec 31, 2023 | 141,000.00 |